Literature DB >> 30304357

Risk score model for predicting complications in patients undergoing ventricular tachycardia ablation: insights from the National Inpatient Sample database.

Sampath Gunda1, Santosh K Padala1, Aditya Saini1, Le Kang2, Kenneth A Ellenbogen1, Jayanthi N Koneru1.   

Abstract

AIMS: Outcome data on ventricular tachycardia (VT) ablation has been limited to few experienced centres. We sought to identify complication rates, predictors, and create a risk score model for predicting complications in patients from real-world data. METHODS AND
RESULTS: A total of 25 451 patients undergoing VT ablation from year 2006 to 2013 were identified from the National Inpatient Sample (NIS) database. The whole cohort was randomly divided into derivation cohort to derive the model and validation cohort to validate the model. Multivariate predictors of any complication were identified using regression model. Each predictor was assigned a risk score and each patient was assigned to one of the four groups (risk score in parenthesis) based on total combined risk score: Group 0 (0), Group 1 (1-5), Group 2 (6-10), and Group 3 (>11). The rate of 'any complication' and 'in-hospital mortality' in whole cohort was 14.7% and 2.8%, respectively. The predictors of any complication include chronic kidney disease, coagulopathy, chronic liver disease, stroke (cerebrovascular accident), emergency procedure, age ≥ 65 years, coronary artery disease, peripheral vascular disease, and female gender. There was a significant increase in complication rate in a linear fashion as the risk score increased. The incidence of any complications increased from 2.7% in Group 0 to 31% in Group 3. The risk score model performed well in predicting complications associated with VT ablation.
CONCLUSION: Patients with higher risk scores have significant increase in any complication and in-hospital mortality from VT ablation. The simple risk score model can help to risk stratify patients prior to VT ablation. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Area under the curve; Cerebrovascular accident; Chronic kidney disease; Chronic liver disease; Chronic obstructive pulmonary disease; Congestive heart failure; Coronary artery disease; Diabetes mellitus; National Inpatient Sample; Peripheral vascular disease; Radiofrequency ablation; Receiver operating characteristic; Ventricular tachycardia

Year:  2019        PMID: 30304357     DOI: 10.1093/europace/euy213

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

Review 1.  Racial disparities in ventricular tachycardia in young adults: analysis of national trends.

Authors:  Harsh P Patel; Samarthkumar Thakkar; Nishaki Mehta; Mohammed Faisaluddin; Rezwan F Munshi; Ashish Kumar; Safi U Khan; Rohan Parikh; Christopher V DeSimone; Garima Sharma; Abhishek Deshmukh; Khurram Nasir; Sarju Ganatra; Sourbha S Dani
Journal:  J Interv Card Electrophysiol       Date:  2022-08-10       Impact factor: 1.759

2.  Novel Risk Model to Predict Emergency Department Associated Mortality for Patients Supported With a Ventricular Assist Device: The Emergency Department-Ventricular Assist Device Risk Score.

Authors:  Jonathan B Edelson; Jonathan J Edwards; Hannah Katcoff; Antara Mondal; Feiyan Chen; Nosheen Reza; Thomas C Hanff; Heather Griffis; Jeremy A Mazurek; Joyce Wald; Danielle S Burstein; Pavan Atluri; Matthew J O'Connor; Lee R Goldberg; Payman Zamani; Peter W Groeneveld; Joseph W Rossano; Kimberly Y Lin; Edo Y Birati
Journal:  J Am Heart Assoc       Date:  2022-01-13       Impact factor: 6.106

3.  Outcome of catheter ablation in the very elderly-insights from a large matched analysis.

Authors:  Kevin Willy; Gerrit Frommeyer; Dirk G Dechering; Kristina Wasmer; Dennis Höwel; Sarah S Welle; Nils Bögeholz; Christian Ellermann; Julian Wolfes; Benjamin Rath; Patrick R Leitz; Julia Köbe; Philipp S Lange; Patrick Müller; Florian Reinke; Lars Eckardt
Journal:  Clin Cardiol       Date:  2020-08-31       Impact factor: 2.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.